Potential impact of antimicrobial resistance in wildlife, environment and human health by Hajer Radhouani et al.
REVIEW ARTICLE
published: 05 February 2014
doi: 10.3389/fmicb.2014.00023
Potential impact of antimicrobial resistance in wildlife,
environment, and human health
Hajer Radhouani 1,2,3,4 †, Nuno Silva 3 †, Patrícia Poeta 3,4 , CarmenTorres 5 , Susana Correia 1,2,3,4 and
Gilberto Igrejas 1,2*
1 Institute for Biotechnology and Bioengineering, Centre of Genomics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
2 Department of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
3 Animal and Veterinary Research Centre, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
4 Veterinary Science Department, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
5 Biochemistry and Molecular Biology Area, University of La Rioja, Logroño, Spain
Edited by:
Jose L. Martinez, Centro Nacional de
Biotecnología, Spain
Reviewed by:
Teresa M. Coque, Hospital
Universitario Ramón y Cajal, Spain
Stefania Stefani, University of
Catania, Italy
*Correspondence:
Gilberto Igrejas, Institute for
Biotechnology and Bioengineering,
Centre of Genomics and
Biotechnology and Department of
Genetics and Biotechnology,
University of Trás-os-Montes and Alto
Douro, 5001-801 Vila Real, Portugal
e-mail: gigrejas@utad.pt
†Hajer Radhouani and Nuno Silva
have contributed equally to this work.
Given the signiﬁcant spatial and temporal heterogeneity in antimicrobial resistance
distribution and the factors that affect its evolution, dissemination, and persistence, it
is important to highlight that antimicrobial resistance must be viewed as an ecological
problem. Monitoring the resistance prevalence of indicator bacteria such as Escherichia coli
and enterococci in wild animals makes it possible to show that wildlife has the potential
to serve as an environmental reservoir and melting pot of bacterial resistance. These
researchers address the issue of antimicrobial-resistant microorganism proliferation in the
environment and the related potential human health and environmental impact.
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INTRODUCTION
Microorganisms play an important role in the cycling of elements
at a global scale, thus profoundly and directly affecting the envi-
ronments, in which all of life evolves. While microorganisms affect
the environment, the environment in turn also engenders evolu-
tionary pressures on the microorganisms themselves (Reid and
Buckley, 2011).
Recent advances in DNA sequencing, high-throughput tech-
nologies, and geneticmanipulation systems have permitted empir-
ical studies that directly characterize the molecular and genomic
bases of evolution (Wagner, 2008; Conrad et al., 2011). This
launched the challenge of unraveling the genotype-phenotype
connection, with implications not only for the investigation of
evolution, but also physiology, disease risk, development, and
biodiversity (Reid and Buckley, 2011).
In microbial populations, evolutionary change is supplied by
two sources of new variation: horizontal transfer of genetic mate-
rial from other, sometimes distantly related species, and mutation.
Though, in the short run, mutation is the primary source of new
genetic variation driving evolutionary change in microbial popu-
lations. In an asexual microbial species, evolutionary changes will
happen by the repeated selection of new clones carrying adaptively
favorable mutations (Adams, 2004).
In fact, ﬁrstly, genomic sequencing can determine the complete
set of mutations responsible for an advanced phenotype, and has
led to the discovery that interactions between these mutations
are very usual. Secondly, adaptive mutations commonly target
regulatory mechanisms. Thirdly, principles of systems-level opti-
mization cause the genetic changes seen in adaptive evolution,
and with a systems-level understanding, these optimization prin-
ciples can be harnessed for the purposes of metabolic engineering.
Fourthly, mutant sub-populations of enhanced ﬁtness invariably
arise in growing populations, but their dynamics in the population
are complicated due to factors such as natural selection, clonal
interference, drift, and frequency-dependent selection (Barrick
et al., 2009).
Antibiotic-resistant bacteria are extremely important to human
health, but the wild reservoirs of resistance determinants are
poorly understood. The origins of antimicrobial resistance in the
wildlife is important to human health because of the increasing
importance of zoonotic diseases as well as the need for pre-
dicting emerging resistant pathogens. Wild animals provide a
biological mechanism for the spread of antibiotic resistance genes.
Antimicrobial-resistant Escherichia coli and Enterococcus spp. iso-
lates originating from wildlife species were reported for the ﬁrst
time from Japanese wild birds (Sato et al., 1978). With the new
millennium several studies, in different continents, have described
the occurrence of antimicrobial-resistant in these bacteria species
in wildlife (Souza et al., 1999; Sherley et al., 2000; Gakuya et al.,
2001; Lillehaug et al., 2005; Skurnik et al., 2006; Dolejska et al.,
2007; Gaukler et al., 2009; Schierack et al., 2009; Allen et al., 2010;
Silva et al., 2010; Marinho et al., 2013; Navarro-Gonzalez et al.,
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2013; Pesapane et al., 2013; Santos et al., 2013). On the other hand,
antimicrobial resistance have been described in others impor-
tant pathogens, such as Salmonella spp. (Botti et al., 2013) and
methicillin-resistant Staphylococcus aureus (MRSA; Porrero et al.,
2013) in wild animals.
Proximity to human activities inﬂuences the antibiotic resis-
tance proﬁles of the gut bacteria of wild mammals, which live
in densely populated microbial habitats in which antibiotics
select for resistance. While various bacterial species are impor-
tant in terms of multiresistance and nosocomial infections in
human and veterinary medicine, we consider the Gram-positive
vancomycin-resistant enterococci (VRE) and Extended-spectrum
Beta-Lactamases producing Gram-negative bacteria like E. coli
(ESBL-E. coli) as being key indicator pathogens to trace the
evolution of multiresistant bacteria in the environment and
wildlife.
Enterococcus spp. are Gram-positive facultative anaerobic bac-
teria, spherical, which occur singly, in pairs or short chains and
ﬁt within the general deﬁnition of lactic acid bacteria (Ciftci
et al., 2009). Most enterococci are not virulent and are consid-
ered relatively harmless, with little potential for human infection.
However, they have also been identiﬁed as nosocomial opportunis-
tic pathogens with increased resistance to antimicrobial approved
agents (Chenoweth and Schaberg, 1990). Incidence of VRE among
wild animals has been reported in several countries (Mallon et al.,
2002; Figueiredo et al., 2009; Ishihara et al., 2013), including in
remote areas (Silva et al., 2011a).
Escherichia coli is the head of the large bacterial family,
Enterobacteriaceae, the enteric bacteria, which are facultatively
anaerobic Gram-negative (Sorum and Sunde, 2001). This intesti-
nal bacterium can be easily disseminated in different ecosystems.
For this reason, fecal E. coli is considered to be an important
indicator for the selective pressure exerted by the use of antimi-
crobials on intestinal populations of bacteria (van den Bogaard
and Stobberingh, 2000). The production of ESBLs by Enterobac-
teriaceae, speciﬁcally by E. coli, has caused a major concern in
several countries, being frequently implicated in human infec-
tions. Previous reports have described ESBL-containing E. coli
strains in healthy wild animals (Pinto et al., 2010; Guenther et al.,
2011).
The common occurrence of antimicrobial resistance in wildlife
has several implications such as: the potential to serve as an envi-
ronmental reservoir and melting pot of bacterial resistance; the
zoonotic potential of enteric bacteria; and the potencial problems
of the medical treatment of wildlife. This review aims to summa-
rize the current knowledge on ESBL-E. coli and VRE in wildlife,
in turn underlining the need for more large scale research, in par-
ticular sentinel studies to monitor the impact of multiresistant
bacteria on wildlife.
PHYLOGENETIC HISTORY AND GENETIC STRUCTURE
The combination of mutation and horizontal transfer has cre-
ated the overall phylogenetic structure of E. coli and enterococci,
resulted to currently recognized four main phylogenetic groups
for E. coli and different species for enterococci; and their respec-
tive lineages. Thus, an appreciation of mutation and horizontal
transfer as important evolutionary processes within bacteria, in
general, contributes in understanding of their roles, distribution
and mechanistic modes of behavior (Johnson, 2002).
Amultilocus enzymeelectrophoresis (MLEE)-basedphenogram
using 38 enzymes (Selander et al., 1986; Goullet and Picard, 1989)
identiﬁed four main phylogenetic groups (A, B1, B2, and D) and
two accessory groups (C and E) in E. coli (Selander et al., 1987;
Herzer et al., 1990; Tenaillon et al., 2010). These phylogenetic
groups were recovered using the 1,878 genes of the Escherichia
spp. core genome and the 2.6 million nucleotides of the E. coli
chromosomal backbone (Touchon et al., 2009), which permitted
a robust phylogeny to be developed; the ﬁrst split in the E. coli
phylogenetic history leads to one branch including the strains of
group B2 and a subgroup within D that we called group F75 and
another branch containing the rest of the species (Touchon et al.,
2009). The remaining strains of group D then appeared from this
secondbranch, followedby groupE (Tenaillon et al., 2010). Finally,
groups A and B1 are sister groups whereas group B2 is included in
an ancestral branch (Jaureguy et al., 2008; Touchon et al., 2009).
The B2 group reveals the highest diversity at both the nucleotide
and the gene content level (Touchon et al., 2009), supporting its
early occurrence in the species lineage and suggesting that it has
subspecies status (Lescat et al., 2009).
Clermont et al. (2000) described a triplex polymerase chain
reaction (PCR) strategy to assign E. coli isolates quickly to one of
these phylogroups. It sought three phylogenetic group markers,
the chuA and yjaA genes encoding hypothetical proteins and the
TSPE4.C2 DNA sequences situated within a gene encoding puta-
tive lipase esterase, and groups were assigned based on different
combinations of presence and/or absence of the three amplicons
(Clermont et al., 2000).
Johnson et al. (2001) found that strains from phylogenetic
groups B2 and D contained more virulence factors than strains
from the phylogenetic groups A and B1. Usually, the extraintesti-
nal pathogenic strains belong to groups B2 and D (Picard et al.,
1999; Johnson and Stell, 2000), the commensal strains to groups
A and B1 (Bingen et al., 1998), whereas the intestinal pathogenic
strains belong to groups A, B1, and D (Pupo et al., 1997).
Nowadays, these phylogenetic groups differ in their ecolog-
ical niches, life-history (Gordon and Cowling, 2003) and some
characteristics, such as their ability to exploit different sugar
sources, their antimicrobial resistance proﬁles and their growth
rate (Carlos et al., 2010). A recent survey (Walk et al., 2007)
demonstrated that the majority of the E. coli strains that are able
to persist in the environment belong to the B1 phylogenetic group
(Carlos et al., 2010).
Various researchers analyzed the distribution of the main phy-
logenetic groups among E. coli strains isolated from human and
animal faces; it was found that the relative abundance of phylo-
genetic groups among mammals is dependent on the host diet,
body mass, and climate (Gordon and Cowling, 2003; Carlos et al.,
2010). A study analyzing fecal strains isolated from birds, non-
humanmammals, and humans, observed the prevalence of groups
D and B1 in birds, A and B1 in non-human mammals, and A and
B2 in humans. These different reports concluded that one of the
main forces that shapes the genetic structure of E. coli popula-
tions among the hosts is domestication (Escobar-Paramo et al.,
2006). Furthermore, other study in the south of French Guiana,
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human strains very rarely were observed as belonging to B2 phy-
logroup (3.7%) whereas wild animal strains were characterized
by 46.1% belonging to B2 phylogroup (Lescat et al., 2013). More-
over, feces from zoo animals were analyzed and a prevalence of
group B1 in herbivorous animals and a prevalence of group A in
carnivorous and omnivorous animals were found (Baldy-Chudzik
et al., 2008). Furthermore, domesticated animals have a decreased
proportion of B2 strains than wild animals (from 30% in wild
animals to 14 and 11% in farm and zoo animals, respectively) and
an increased proportion of A strains (from 14% in wild animals to
27 and 26% in farm and zoo animals, respectively; Tenaillon et al.,
2010).
In Portugal, the prevalence of E. coli of groups A and B1 was
observed in wild birds as seagulls (Radhouani et al., 2009), birds
of prey (Radhouani et al., 2012b), and Passeriformes (Santos et al.,
2013), but also in wild mammals as Iberian lynxes (Gonçalves
et al.,2012a), red foxes (Radhouani et al.,2013), and in Iberianwolf
(Gonçalves et al., 2013a; Figure 1). In addition, a report conducted
by Simões et al. (2010) shows that 37% of all ESBL-E. coli isolated
from seagulls belong to B2 or D phylogroup, a higher rate than
previously reported (27% of all E. coli; Poeta et al., 2008).
It is interesting to note that fecal samples from red foxes showed
that the E. coli isolates from phylogenetic groups A and D were
predominant. Similar results were observed in chickens and swine
(Machado et al., 2008), in wild boars (Poeta et al., 2009) and in
wild birds (Radhouani et al., 2010a,b) in the same geographical
area.
With the exception of E. faecium and E. faecalis, the enterococci
are infrequently described to be involved in human pathogene-
sis (Jett et al., 1994; Devriese and Pot, 1995). Though, in some
countries association of strains of E. faecalis and E. faecium with
human disease has reached proportions of serious concern (Jett
et al., 1994; Leclercq, 1997; Fisher and Phillips, 2009). However,
these enterococci species can show signiﬁcant differences in the
incidence of virulence factors and antimicrobial resistance. Gen-
erally, E. faecalis appears to harbor more virulence traits while
E. faecium strains were generally free of virulence factors (Eaton
and Gasson, 2001). In addition, considering the distribution of
the antimicrobial resistance according to the species, the E. fae-
cium possessed a higher level of resistance than E. faecalis (Gin
and Zhanel, 1996; Franz et al., 2001). Actually, the majority of
hospital-derived isolates of E. faecalis cluster in three clonal com-
plexes, CC2, CC9, and CC87, and included the highest proportion
of multiresistant isolates. (Ruiz-Garbajosa et al., 2006; van Schaik
and Willems, 2010; Weng et al., 2013), while the CC17 is a major
groupof genetic lineage of E. faecium that haswidely spreadworld-
wide and it is associated with hospital outbreaks (Willems et al.,
2005;Willems and van Schaik, 2009). AlthoughE. faecalis CC2 and
CC9 strains has been detected outside hospitals in farm animals
and environment (Freitas et al., 2011; Novais et al., 2013), to our
knowledge has not been identiﬁed in wild animals. On the other
hand, E. faecium CC17 was recovered from seagulls in Portugal
(Radhouani et al., 2010c).
Recent comparisons of available genome sequences support the
concept of a hospital-associated clade that is genetically distinct
frommost commensal isolates fromanimals andhumans (Willems
and van Schaik, 2009; van Schaik and Willems, 2010; Werner et al.,
2011; Galloway-Pena et al., 2012). In Portugal, concerning wild
animals, E. faecium were found to be the main species in seagulls
(Radhouani et al., 2011b); birds of prey (Radhouani et al., 2012b),
partridges (Silva et al., 2011b), Iberian wolf (Gonçalves et al.,
2013a), red foxes (Radhouani et al., 2013), wild boars (Poeta
et al., 2007a), gilthead seabream (Barros et al., 2011), and Echin-
oderms (Marinho et al., 2013), while E. faecalis was dominant
in Passeriformes (Santos et al., 2013) and wild rabbits (Silva
et al., 2010). On the other hand, E. hirae was the predomi-
nant specie isolated from Iberian lynx (Gonçalves et al., 2013b,c;
Figure 2).
FIGURE 1 | Phylogenetic group distributions of E. coli in wild animal from Portugal.
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FIGURE 2 | Distribution of Enterococcus species in wild animals from Portugal.
Along with seagulls and birds of prey in Portugal, migratory
Canada geese report showed also the occurrence of E. faecium and
E. faecalis species. Furthermore, different reports found that all
enterococci isolates detected inwildmammals (Mallon et al., 2002)
and also in glaucous gulls (Drobni et al., 2009) were E. faecium
species. Another study performed in Brazil, showed the occur-
rence of E. faecalis in non-human primate (capuchin monkeys
and common marmoset) fecal samples (Xavier et al., 2010). In
American bison fecal samples, E. casseliﬂavus was the predomi-
nant species recovered with 62.4%, followed by E. faecalis (16%;
Anderson et al., 2008).
With the arrival of next-generation sequencing (Mardis, 2008),
it was quickly possible to investigate hundreds of strains to get a
better knowledge at the whole-genome level the evolutionary pro-
cesses acting in populations (Liti et al., 2009; MacLean et al., 2009;
Schacherer et al., 2009), opening the era of “population genomics”
(Tenaillon et al., 2010). Certainly further studies using new high
throughput technologies are mandatory to completely understand
the evolution of predominant clones and species in different hosts
and environments (Santagati et al., 2012).
DIVERSITY AND COMPLEXITY OF BACTERIAL NICHES
VIRULENCE FACTORS
Large-scale epidemiological studies provide insight into the diver-
sity and complexity of E. coli and enterococci niches (Tenaillon
et al., 2010; Arias and Murray, 2012). Thus, genome plasticity has
contributed to the emergence of new virulence traits: some clus-
ters of genes or genomic islands, including pathogenicity islands
(PAIs) should be discovered only in a subset of strains and favored
in some speciﬁc environments. Furthermore, several alternative
combinations of genes could promote similar adaptations to a
given environment (Tenaillon et al., 2010). Gene gain and loss
make fundamental contributions to new habitat adaptation and
the emergence of new lineages (Dagan and Martin, 2007). Strains
related to hospital infectionswere found tohave signiﬁcantly larger
overall average genome size than strains from non-hospitalized
humans or animals groups (Lebreton et al., 2013). The prevalence
of virulence factors genes is variable among commensal popula-
tions. On a global scale, the human microbiota is characterized
by a higher prevalence of virulence genes than the microbiota of
other organisms (Skurnik et al., 2008). In animals, the presence
of virulence genes increases with body mass, which reveals the
gut complexity of larger animal (Skurnik et al., 2008). Thus, vir-
ulence factors and their change in prevalence among hosts may
reﬂect some local adaptation to commensal habitats rather than
virulence per se (Tenaillon et al., 2010).
INTRA-SPECIES INTERACTIONS
Interactions between community members are required for com-
munity development and maintenance; and can also drive some
diversiﬁcation. Many genes that are carried by mobile elements
code for traits that are expressed outside of the cell. Such traits
are involved in bacterial sociality, such as the production of pub-
lic goods, which beneﬁt a cell’s neighbors, or the production of
bacteriocins, which harm a cell’s neighbors. To out-compete other
clones, the production of colicins can represent a useful strategy
in a structured environment (Chao and Levin, 1981). Colicins
are the most expansively studied bacteriocins produced by E. coli.
This couldpermit unadapted strains to colonize the gut and, hence,
allow numerous clones to coexist in the long term. It may also pro-
mote diversiﬁcation in a clone, as some strains may try to beneﬁt
from the production of the colicin but avoid paying the associ-
ated cost. However, the secretion of bacteriocins can be deﬁned
as a “spiteful” behavior in which are costly for the producer and
cause harm to other members of the population (Rankin et al.,
2011).
Horizontal gene transfer is a key step in the evolution of
bacterial pathogens. Chromosomal structures such as PAIs have
been shown to extensively contribute to the evolution of bacterial
pathogens by providing dynamic changes of the bacterial genome
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composition leading to a bacterial evolution in quantum leaps.
Different mechanisms have been proposed for transfer of PAIs
across the species border including phage transfer, mobilization
by conjugative transposons and plasmids (Schubert et al., 2009).
The fact that these microorganisms are less virulent than oth-
ers is not reassuring, since the acquirement of virulence genes by
bacteria is possible (Leclercq, 1997). Further research is required
to characterize molecular and cellular interactions between the
host and enterococci which lead to intra-species genetic transfer
and virulence factors in enterococci species (Giridhara Upadhyaya
et al., 2009).
ANTIMICROBIAL RESISTANCE
Antimicrobial resistance is a worldwide problem in human and
veterinary medicine. Commonly, it is usual that the major risk
factor for the increase of this situation is an extensive use of
antimicrobials that leads to the dissemination of resistant bacteria
and resistance genes in animals and humans (van den Bogaard
and Stobberingh, 2000). The appearance of multiresistant bac-
teria of human and veterinary origin is probably accompanied
by co-contamination of the environment apparently leading to a
great health concern (Grobbel et al., 2007). As in the hospital envi-
ronment, the agricultural use of antimicrobials agents selects for
antibiotic resistance. These antimicrobial drugs frombothhospital
and agricultural sources can persist in soil and aquatic environ-
ments, and the selective pressure imposed by these compounds
may affect the treatment of human diseases (Thiele-Bruhn, 2003;
Segura et al., 2009). In addition, the prophylactic use of antibiotics
in ﬁsh farms has led to a rise in the number of resistant bacte-
ria (Cabello, 2006). However, the use of antibiotics by humans is
not the only selective pressure for antibiotic resistance in natural
microbial communities: compounds and conditions that occur in
these communities may provide additional selection pressures. In
fact, most antimicrobial agents are produced by strains of fungi
and bacteria that occur naturally in all environments, including
soil (Martin and Liras, 1989).
Bacteria may also acquire resistance determinants without
direct exposure to an antimicrobial through horizontally mobile
elements including conjugative plasmids, integrons, and trans-
posons (Middleton and Ambrose, 2005). These mobile elements
can simply transfer antimicrobial resistance genes from one bac-
terium to another (Coque et al., 2008). Antimicrobial agents exert
a selective pressure not only on pathogenic, but also on commen-
sal bacteria of the intestinal tract of humans and animals (van den
Bogaard and Stobberingh, 2000). In a broader view, increasing evi-
dence suggests that components such as integrons and their gene
cassettes played signiﬁcant roles in genome evolution and ﬂuid-
ity within the bacterial kingdom (Duriez et al., 2001; Davies and
Davies, 2010).
In E. coli, the phylogenetic group A strains (Mammeri et al.,
2009) and some group D strains (Deschamps et al., 2009) are
especially permissive to the development of resistance to third-
generation cephalosporins. Conversely, phylogenetic group B2
strains are less resistant than the remaining strains (Picard and
Goullet, 1989; Johnson et al., 1991, 1994), regardless of the molec-
ular mechanism implicated in the acquisition of resistance, and
have a lower prevalence of integrons in commensal E. coli strains
from both human (Skurnik et al., 2005) and animal hosts (Skurnik
et al., 2006). This could reveal the relative decrease of phylogenetic
group B2 strains in domesticated animals in which antimicrobials
are used considerably (Tenaillon et al., 2010).
The class of beta-lactam antibiotics is among the most impor-
tant groups of antimicrobial agents in human and veterinary
medicine. Besides the ﬁrst widely used antimicrobial substance
penicillin, other members of this family have gained a similar
importance over the last decades, namely the ﬁrst- to fourth-
generation cephalosporins and the beta-lactamase-inhibitors. All
beta-lactams interfere with the ﬁnal stage of peptidoglycan syn-
thesis through acting on penicillin-binding proteins, thereby
preventing the bacterial cell wall from forming. Themost common
resistance mechanism of Enterobacteriaceae spp. against beta-
lactams is the inactivation of the antibiotic by breaking up the
nitrogen-carbonyl bond in the beta-lactam ring (Walsh, 2003).
The emergence and wide dissemination of ESBLs among clinical
E. coli isolates in hospitals, has caused a major concern in sev-
eral countries, being frequently implicated in human infections.
These infections have a great impact on public health due to an
increased incidence of treatment failure and severity of disease.
ESBLs mainly include TEM, SHV, and CTX-M enzymes. Among
them, the highest number of variants described in the last years
corresponds to the CTX-M family (Naas et al., 2007). The pres-
ence of CTX-M enzymes render E. coli resistant to a variety of
beta-lactams, and are transferred via plasmids that can also include
resistance genes to several unrelated classes of antimicrobial agents
(Canton et al., 2012).
Carbapenems such as imipenem or meropenem possess the
most consistent activity against ESBL-producing Enterobacteri-
aceae strains. Both antibiotics are considered the agents of choice
in the treatment of infections due to ESBL-producing organisms
(Nordmann et al., 2011) However, Enterobacteriaceae-producing
carbapenemases have rapidly emerged and disseminated world-
wide, including in the wild (Fischer et al., 2013). The carbapene-
mases, such as the New Delhi metallo-beta-lactamase 1 (NDM-1)
hydrolyze all β-lactam antibiotics, including carbapenems, and
their high potential for rapid, wide dissemination constitutes a
major clinical and public health threat (Nordmann et al., 2009;
Nordmann et al., 2011).
The increase in the occurrence of nosocomial infections caused
by enterococci in particular E. faecium, is at least partly due to
the wide variety of intrinsic and acquired resistances to glycopep-
tides and aminoglycosides, among others, posing a challenge to
therapeutic options. Moreover, infections caused by other Ente-
rococcus species (E. faecalis, E. durans, E. mundtii, E. avium, E.
rafﬁnosus, E. gallinarum, and E. casseliﬂavus) occasionally occur
and warrant attention (Murray, 1990; Prakash et al., 2005). Ente-
rococci are expert in acquiring and transferring elements that
confer resistance to antimicrobials and they are also known to
be intrinsically resistant to numerous antimicrobials. As a result,
therapeutic alternatives for treatment of enterococcal infections
are increasingly limited (Murray, 1990). Evolution of enterococci
toward resistance to multiple antimicrobials is also a major cause
of concern.
The acquisition of vancomycin resistance by enterococci has
seriously affected the treatment and infection control of these
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organisms. Different types of glycopeptide resistance and their
biochemical mechanisms have been described in enterococci:
acquired type (vanA, vanB, vanD, vanE, vanG, and vanL); and
low-level intrinsic type (vanC, associated with the E. gallinarum,
E. casseliﬂavus, and E. ﬂavescens species). VanA-type resistance,
which was the ﬁrst to be elucidated and which is the most
common, is characterized by high levels of resistance to gly-
copeptides, vancomycin, and teicoplanin and is mediated by
transposon Tn1546 or closely related elements that are chro-
mosomally or plasmid located (Arthur et al., 1996). The devel-
opment of newer antimicrobial drugs, such as linezolid and
daptomycin with activity against many VRE strains (Lee et al.,
2007). has improved this situation; however resistance to these
agents has already been described (Miller et al., 2013; Patel et al.,
2013).
WILDLIFE AS RESERVOIRS OF ANTIBIOTIC RESISTANCE
An important difﬁculty in evaluating the causal relationship
between antimicrobial use and resistance is the confounding inﬂu-
ence of geography: the co-localization of resistant bacterial species
with antimicrobial use does not essentially involve causation and
could represent the presence of environmental conditions and
factors that have independently contributed to the incidence of
resistance (Singer et al., 2006).
The collection of all antimicrobial resistance genes and their
precursors in pathogenic and non-pathogenic bacteria and also
in antimicrobial producing-organisms is referred as the antimi-
crobial resistome, a concept that has been advanced to serve as a
framework for understanding the ecology of resistance on a global
scale (Wright, 2010).
Usually, wildlife is not exposed to clinical antimicrobial agents
but can acquire antimicrobial-resistant bacteria through con-
tact with humans, animals and the environment, where water
polluted with feces appears to be the most signiﬁcant vector
of contamination. The incidence of commensal and pathogenic
bacteria in fecal contaminations can be expected to be a con-
nection between the environment and settings with regular or
even constant antimicrobial pressure (aquaculture, livestock farm-
ing, human, and veterinary clinical settings), resulting in a
constant release of antimicrobial-resistant human and animal
bacteria into the environment through wastewater or manure
(Martinez, 2009). Additionally, the detection of antimicrobial-
resistant bacteria in aquatic environments affected by human and
animal wastewater and soil provides evidence for this hypothesis
(Kummerer and Henninger, 2003). In this context the common
use of antimicrobials in aquaculture is also of utmost impor-
tance due to possible direct inﬂuences on wild animals (Smith,
2008). As intestinal bacteria like E. coli and enterococci can
be easily disseminated in different ecosystems through water,
they are intensively used as indicator species for fecal pollution
(Guenther et al., 2011). In this sense, it is essential to interpret
the evolutionary and ecological forces that inﬂuence in the pop-
ulation structure of the commensal strains to fully understand
the antimicrobial resistance and virulence of pathogenic strains.
Certainly, the selective pressures in the habitats of commensal
strains may coincidentally promote the emergence of antimi-
crobial resistance and virulence factors, rendering commensal
strains reservoirs of virulent and resistant strains (Tenaillon et al.,
2010).
Despite the commensal character of E. coli and enterococci,
they are commonly involved in animal and human infections that
implicate the use of antimicrobials, which increases public health
preoccupations to the list of implications that arise from the spread
of ESBL-E. coli andVRE into wildlife. Furthermore, the increasing
frequency of community-acquired ESBL-E. coli and VRE infec-
tions and the occurrence in livestock farming has been observed
recently, suggesting a successful transmission as well as persistence
of ESBL-E. coli andVRE strains outside hospital settings. An addi-
tional parallel global phenomenon is the spread of ESBL-E. coli
and VRE into the environment beyond human and domesticated
animal populations, and this appears to be directly induced by
antimicrobial practice (Guenther et al., 2011). This might be a
signiﬁcant cause of the community-onset of ESBL-E. coli and
VRE infections but can result (i) in an involvement of wildlife in
ESBL-E. coli and VRE spread and transmission into fragile envi-
ronmental niches, (ii) in subsequent colonization of wild animal
populations which can turn into an infectious source or even a
reservoir of ESBL-E. coli and VRE, (iii) in new putative infection
cycles between wildlife, domesticated animals and humans, and
(iv) in difﬁculties of wildlife medical treatment (Guenther et al.,
2011).
Monitoring the prevalence of resistance in indicator bacteria
such as fecal E. coli and enterococci in different populations (ani-
mals, patients and healthy humans) makes it possible to compare
the prevalence of resistance and to detect transfer of resistant bac-
teria or resistance genes from animals to humans and vice versa
(Martel et al., 2001). Just recently, there has been increasing inter-
est in resistant bacteria and resistance genes isolated from wild
animals (Allen et al., 2011).
The degree of colonization varies a lot between different ani-
mal species (Gordon and Cowling, 2003). Therefore, ESBL-E. coli
and VRE prevalence is clearly inﬂuenced by sampling schemes, by
geographic regions, by host spectrum of these bacteria and by the
degree of synanthropic behavior shownbyhost species (Allen et al.,
2010). It is important also to take in consideration the limitations
that occur interpreting these results. For instance, ESBL-E. coli
prevalence in different Portuguese geographical areas ranged from
0.5% in birds of the remote Azores islands in the Atlantic Ocean
(Silva et al., 2011a) to 32% for birds of the Portugal’s North-
ern Portuguese coast (Simões et al., 2010). A lower prevalence
of ESBL-E. coli was also observed (0.8%) in glaucous-winged
gulls of Kamchatka peninsula in Russia (Hernandez et al., 2010).
These ﬁndings suggest that wild animals living in urban areas are
more susceptible to carry ESBL-E. coli than those living in remote
areas.
Due to their diversity in ecological niches and their ease in pick-
ing up human and environmental bacteria, wild birds might act
as mirrors of human activities. Within the heterogeneous class
of birds, two groups seem to be in the focus of ESBL-E. coli
and VRE carriage in wildlife: birds of prey (Costa et al., 2006;
Pinto et al., 2010; Radhouani et al., 2010a,b; Silva et al., 2011a)
and waterfowl/water related species (Poeta et al., 2008; Bonnedahl
et al., 2009; Dolejska et al., 2009; Guenther et al., 2010a; Hernandez
et al., 2010; Literak et al., 2010a; Radhouani et al., 2010c; Simões
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et al., 2010; Garmyn et al., 2011). However, recent studies in Passer-
iformes have also described a signiﬁcant incidence of VRE (Silva
et al., 2011a, 2012; Oravcova et al., 2013a,b).
Although wild birds, such as birds of prey, have only rare con-
tact with antimicrobial agents, in disagreement with the existence
of direct selective pressure, they can be contaminated or colo-
nized by resistant bacteria. Water contact and acquisition via food
seem to be major aspects of transmission of resistant bacteria of
human or veterinary origin to wild animals (Cole et al., 2005). In
the other hand, wild birds such as seagulls are often opportunistic
marine feeders along the shoreline or offshore, but also eat the
food sources provided by humans, especially garbage. Migrating
birds that travel long distance seem to act as transporters, or as
reservoirs, of resistant bacteria and may consequently have a sig-
niﬁcant epidemiological role in the dissemination of resistance,
as well as being mirrors of the spectrum of pathogenic microor-
ganisms present in humans (Radhouani et al., 2010c; Silva et al.,
2011a). Reports on marine ﬁsh showed the presence of ESBL-
E. coli (Sousa et al., 2011) andVRE (Barros et al., 2012) in gilthead
seabream, indicating a dissemination of ESBL-E. coli andVRE into
the Atlantic ocean. Moreover, it has previously been demonstrated
that seagulls shared strains with isolates cultured from wastewater
treatment plants and landﬁlls (Nelson et al., 2008). This highlights
the possibility of bacterial exchange between human sewage and
birds.
Another important host of these bacteria appears to be in wild
rodents. Although these animals have previous been in the focus
of research on ESBL in wildlife in different continents (Gilliver
et al., 1999; Kozak et al., 2009; Guenther et al., 2010b; Literak et al.,
2010b; Allen et al., 2011), they have only been detected in urban
rats (Guenther et al., 2010a; Ho et al., 2011). On the other hand,
VRE have been earlier described in wild rodents (Mallon et al.,
2002). This synantropic species can easily pickup human waste
and frequently interacts with human feces in the sewage system in
urban environments and can therefore easily acquire multiresis-
tant bacteria. Remarkably, wild boars have also been described as
hosts of these bacteria in Europe, whichmight expose their omniv-
orous feeding behavior (Poeta et al., 2007b, 2009; Literak et al.,
2010b). Recent studies revealed the presence of ESBL-producing
E. coli (Gonçalves et al., 2012a,b) and VRE isolates (Gonçalves
et al., 2011) in Iberian wolf and/or Iberian lynx. The incidence
of ESBL-E. coli (Radhouani et al., 2012a) and VRE (Radhouani
et al., 2011a) in red foxes may be due their diet as these wild
animals usually hunt wild rabbits, small rodents and birds. It
is important to point out that some studies reported the pres-
ence of antimicrobial-resistant isolates in wild rabbits (Figueiredo
et al., 2009; Silva et al., 2010) and wild rodents (Kozak et al., 2009;
Guenther et al., 2010b). Foxes are on topof the food chain, perhaps
accumulating multiresistant bacteria from their prey (Grobbel
et al., 2012). All these evidences may contribute in the acquisition
and spread of antimicrobial-resistant bacteria even in the absence
of direct antimicrobial pressure.
These wild animals act as reservoirs of resistance genes and they
could spread resistant bacteria throughout the wild environment.
These researchers address the issue of antimicrobial-resistant
microorganism proliferation in the environment and the related
potential human health and environmental impact.
The level of resistant bacteria detected in wild animals seems
to relate well with the degree of association with human activity
(Skurnik et al., 2006). In fact, human density, natural preservation
state, livestock or the reserve of an area may be signiﬁcant crite-
ria for the proliferation of antimicrobial-resistant bacteria (Allen
et al., 2010). Nevertheless, several studies report the occurrence
of multidrug-resistant bacteria in remote places or preserva-
tion areas therefore underlining the complexity of the spread of
antimicrobial resistance in wild animals. These discoveries pro-
pose, on one hand, an inﬂuence of migratory behavior of wild
birds into remote areas, or on the other hand the omnipres-
ence of human inﬂuence in various ecological niches of the
planet via human feces (Guenther et al., 2011). Different reports
showed that areas with high livestock and human density and
an assumable frequent interaction of wildlife with human inﬂu-
enced habitats of any kind (livestock farms, landﬁlls, sewage
systems, or wastewater treatment facilities) result in a higher risk
for wildlife to acquire antimicrobial-resistant bacteria (Allen et al.,
2010).
CONCLUSION
The strength of trillions upon trillions of microorganisms, com-
bined with the ancient force of evolution by constant, insistent
variation, will inevitably overpower the drugs. Their spectrum is
selected to involve pathogenic bacteria and antimicrobials con-
stantly select naturally resistant bacteria (American Academy of
Microbiology, 2009). As bacteria quickly evolve to acquire resis-
tance to the available antimicrobials, it is a constant race for
scientists to develop effective strategies to combat infection and
to reveal new therapeutic targets (Davies and Davies, 2010).
Moreover, antimicrobial resistance evolving and spreading
among bacterial pathogens is a public health problem of increas-
ing magnitude. Since the beginning of the antimicrobial era, the
selective pressure caused by the use of antimicrobials in clinical,
veterinary, husbandry, and agricultural practices is considered
the major factor responsible for the occurrence and spread of
antimicrobial-resistant bacteria. The evolution of antimicrobial
resistance in bacteria is related to the evolution of antimicro-
bial production. Though, resistance has also been discovered
in the absence of antimicrobial exposure, as in bacteria from
wildlife, raising an interest about the mechanisms of emergence
and persistence of resistant strains under similar conditions,
and the implications for resistance control strategies (Pallecchi
et al., 2008). Monitoring antimicrobial resistance in wildlife from
remote areas could also be a useful tool to evaluate the impact of
anthropic pressure (Thaller et al., 2010).
Singer et al. (2006) support that in ecological studies of antimi-
crobial resistance, there has possibly been too much focus on
resistant organisms and not enough on resistance genes. Due
to the capability of bacteria to transfer resistance genes, even
among distantly related bacteria, analyses of antimicrobial resis-
tance emergence, dissemination and persistence might be better
conducted at the gene level (Singer et al., 2006).
Until now, genomics-based investigation into E. coli and
enterococci has focused on the identiﬁcation of genes directly
implicated in virulence. However, the fundamental physiology
and response mechanisms to environmental conditions of E. coli
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and enterococci remained relatively poorly understood. This is
a serious oversight because during infection the microbial ﬁt-
ness is an important reason in the success of any microbial
pathogen. Further genome-wide reports aiming to deﬁne genes
that are important during infection and colonization or exposure
to antimicrobials will deliver signiﬁcant data on relevant aspects of
E. coli and enterococcal biology. This knowledge can consequently
be useful for the development of novel treatment approaches to
combat microbial infections.
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